In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

There are now multiple forms of injectable PrEP medications. Lenacapavir, which is Gilead's injectable drug, differs from ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Defendant Yisel Lopez has been found in contempt for violating an asset freeze order through the sale of property.

Yuhan sealed a $80.9 million deal with California-based Gilead Sciences to supply pharmaceutical ingredients for the ...

Wesley Sundquist, Ph.D., chair of the Department of Biochemistry, was awarded the 2024 Louisa Gross Horwitz Prize.

Expansion and export plan a step towards getting the US Food and Drug Administration (FDA) certification, says chief ...

South Korean pharmaceutical giant Yuhan announced Friday it has terminated its collaboration with Janssen Biotech on the ...

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Now, Gilead Sciences and MSD have data on a new combination that provides viral suppression with an oral dose given once a week. The phase 2 study – reported at the Conference on Retroviruses ...